clotrimazole has been researched along with eicosapentaenoic acid in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Horrobin, DF | 1 |
Aktas, BH; Grubissich, L; Halperin, JA; Harbinski, F; Ozdelen, E; Qiao, Y; Schubert, R; Sevinc, S; Singer, S | 1 |
3 other study(ies) available for clotrimazole and eicosapentaenoic acid
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A low toxicity maintenance regime, using eicosapentaenoic acid and readily available drugs, for mantle cell lymphoma and other malignancies with excess cyclin D1 levels.
Topics: Angiogenesis Inhibitors; Cell Cycle; Clotrimazole; Cyclin D1; Cyclooxygenase Inhibitors; Eicosapentaenoic Acid; Humans; Lymphoma, Mantle-Cell; Protein Biosynthesis; Thalidomide | 2003 |
Small-Molecule targeting of translation initiation for cancer therapy.
Topics: Animals; Antineoplastic Agents; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Chromans; Clotrimazole; Cyclin D1; Disease Models, Animal; Eicosapentaenoic Acid; Eukaryotic Initiation Factor-2; Female; Humans; Mice; Mice, Inbred DBA; Peptide Chain Initiation, Translational; Phosphorylation; Protein Biosynthesis; Random Allocation; Thiazolidinediones; Troglitazone; Xenograft Model Antitumor Assays | 2013 |